Remaxol® Used in the Treatment of Patients With Gallstone Disease Complicated With Obstructive Jaundice

Clinical trial NCT05928286 · COMPLETED

Trial details

NCT number: NCT05928286
Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company
Status: COMPLETED
Study type: OBSERVATIONAL

Gallstone Disease Obstructive Jaundice

Start date: 2022-12-01
Primary completion: 2025-09-01
Enrollment: 286

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.